技術(shù)文章
Bremelanotide,189691-06-3,1607799-13-2,布雷默浪丹 PT 141
發(fā)布時間:2023-6-13Bremelanotide,布雷默浪丹 PT 141,布美諾肽
Product structure:

Product specifications:
1.CAS No:189691-06-3/1607799-13-2
2.Molecular formula:C50H68N14O10
3.Molecular weight:1025.063
4.density: 1.43
5.Packaging specification:1g、5g、10g, flexible packaging, including 100mg packaging and 500mg 1g and 5g large packaging
6.Dissolution conditions:DMSO (Slightly), Methanol (Slightly), Water (Slightly, Sonicated)
7.Stability:-1 year at 20 ° C, dry and dark.
8.Acidity coefficient(pKa):3.37±0.70(Predicted)
Reaction characteristics:
Bremelanotide(布雷默浪丹 PT 141)一般應用在藥物多肽上,作為多肽中間體,PT-141, a drug used to treat female sexual dysfunction, has shown positive results in phase clinical trials administered to normal premenopausal women.
Matters for use:
It is sensitive to light and temperature. In order to use the reagent effectively, the material should always be kept in a low temperature dry condition, away from light, and avoid frequent thawing and freezing.
storage conditions:
Store at - 20 ℃ as much as possible. If conditions permit, the material can be treated under inert gas to obtain better stability of the reagent.
【 reagent related products】
Cyclo(Phe-Ser)
cyclo(Phe-Pro)
cyclo(Phe-Phe)
cyclo(Leu-Trp)
Cyclo(D-Leu-D-Pro)
cyclo(Leu-Phe)
cyclo(His-Phe)
cyclo(Gly-Trp)
cyclo(Gly-Ser)
cyclo(Gly-Pro)
cyclo(Gly-Phe)
cyclo(Gly-His)
cyclo(Glu-Gly)
cyclo(Gln-Gly)
cyclo(Glu-Glu)
以上編輯的試劑信息僅用于科學研究或者工業(yè)應用等非醫(yī)療目的,非藥用,非食用。接受各種復雜定制服務,合成的Monodispersed PEGs除了有更多樣的基團還可以提供各種不同數(shù)量的PEG的產(chǎn)品。
供應商:西安凱新生物科技有限公司
制藥網(wǎng)
仙居县|
惠东县|
油尖旺区|
三都|
新邵县|
安顺市|
澜沧|
囊谦县|
甘谷县|
翼城县|
昌邑市|
合肥市|
当阳市|
瑞昌市|
巴东县|
郑州市|
临清市|
洞头县|
肥乡县|
当雄县|
芦溪县|
正定县|
渭南市|
昭平县|
延吉市|
全南县|
彰化县|
韶关市|
栾城县|
东安县|
江都市|
澄城县|
无锡市|
肇庆市|
综艺|
台前县|
蓝田县|
浦城县|
惠东县|
边坝县|
建瓯市|